Efficiency Programs And AI Digitalisation Will Support Margins While Legal Risks Remain Manageable

Catalysts

About Humana

Humana is a Nordic care provider focused on specialized social and health care services across Sweden, Norway and Finland.

What are the underlying business or industry changes driving this perspective?

• Although the efficiency program and AI driven digitalization are starting to support margins in Sweden, the need for continued investment in systems and temporary implementation costs could limit how much of the operational improvement actually flows through to EBIT and earnings.
• While occupancy is improving in Swedish Adult and Elderly care and in Finnish Child and Youth, the reliance on filling remaining unused capacity in Child and Youth and disability care, along with slow regulatory processes for permit changes, may slow revenue growth and delay margin expansion.
• Despite new elderly care homes, LSS group homes and bolt on acquisitions adding approximately SEK 140 million in yearly revenues and additional turnover in Norway and Sweden, integration costs, ramp up periods and growth costs in Finland suggest that near term revenue additions may not fully translate into higher net margins.
• Although centralized sales and marketing structures in Finland and Sweden are starting to support occupancy and pipeline building, the history of negative organic growth over the last 12 months and ongoing customer outflow in Personal Assistance mean that revenue growth and EBIT improvement could remain modest until these efforts are fully embedded.
• While Humana benefits from long term demand for specialized care and disability services, legal processes in Norway and Sweden related to overtime compensation and the IVO case, along with ongoing share buybacks and acquisitions, introduce potential cost and capital allocation pressures that could weigh on free cash flow and earnings stability.

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more pessimistic perspective on Humana compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
• The bearish analysts are assuming Humana's revenue will grow by 3.3% annually over the next 3 years.
• The bearish analysts assume that profit margins will increase from 2.0% today to 3.4% in 3 years time.
• The bearish analysts expect earnings to reach SEK 370.8 million (and earnings per share of SEK 7.87) by about July 2029, up from SEK 200.0 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as SEK412.5 million.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 8.7x on those 2029 earnings, down from 14.9x today. This future PE is lower than the current PE for the GB Healthcare industry at 17.7x.
• The bearish analysts expect the number of shares outstanding to decline by 4.65% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 6.89%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• Ongoing efficiency programs, AI driven digitalisation and new ERP systems are already starting to support margins in Sweden and Finland. If these investments continue to translate into structurally higher operating efficiency, EBIT and earnings could trend higher than expected, which may support a higher share price through improved profitability.
• Humana is signing new elderly care homes and LSS group homes that are already filling quickly, while also acquiring higher margin units such as Homsan and Familiehjelpgruppen and expanding specialized offerings in areas like Child and Youth and disability. If long term demand for these services stays firm, occupancy and revenue could rise more than assumed, supporting stronger earnings.
• Management is focused on reducing customer outflow in Personal Assistance and expects net zero outflow. New centralized sales and marketing structures in Sweden and Finland are already contributing to better occupancy and pipeline quality, and if these measures keep gaining traction, organic revenue growth and EBIT could improve beyond a flat share price scenario.
• Humana is actively allocating capital to bolt on acquisitions, dividends and share buybacks, with treasury shares now at 8.3% of the total. If free cash flow remains sufficient to sustain this level of capital returns alongside growth investments, earnings per share and investor demand for the stock could increase.
• Legal processes in Norway related to overtime compensation and in Sweden concerning the IVO case are currently assessed by management as manageable and partly nonrecurring. If the eventual financial impact turns out to be limited while operational improvement continues, risk perceptions could ease and support higher valuation multiples and a stronger share price.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for Humana is SEK64.0, which represents up to two standard deviations below the consensus price target of SEK68.5. This valuation is based on what can be assumed as the expectations of Humana's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of SEK73.0, and the most bearish reporting a price target of just SEK64.0.
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be SEK11.0 billion, earnings will come to SEK370.8 million, and it would be trading on a PE ratio of 8.7x, assuming you use a discount rate of 6.9%.
• Given the current share price of SEK62.8, the analyst price target of SEK64.0 is 1.9% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.